ologen Collagen Matrix
Commercial- Indications
- Glaucoma, Ocular tissue repair
Company intelligence / Profile preview
Aeon Astron Europe
Leiden, South Holland, Netherlandslinkedin.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Aeon Astron Europe develops and markets regenerative biomaterials for ophthalmic surgery and tissue engineering. Its lead product ologen Collagen Matrix is approved in major markets for use in eye surgeries such as glaucoma filtration procedures. The company also developed BioCornea—a fish scale-derived biocornea—for emergency management of corneal perforations, which has completed at least one clinical trial.
- Therapeutic areas
- OtherDermatologyOphthalmology
- Modalities
- BiologicBiomaterial
- Industry
- Implantable Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Aeon Astron Europe.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aeon Astron Europe.